Cowen And Company, LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Cowen And Company, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 05, 2022	SELL	$31.71 - $43.0 $434,427 - $589,100	-13,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $110,556 - $137,048	3,700 Added 37.0%	13,700 $112,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $256,100 - $351,000	-10,000 Reduced 50.0%	10,000 $57,000
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $1.06 Million - $1.28 Million	-31,600 Reduced 61.24%	20,000 $53,000
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $1.23 Million - $1.69 Million	35,700 Added 224.53%	51,600 $28,000
Q1 2021 May 04, 2021	BUY	$42.51 - $63.78 $675,909 - $1.01 Million	15,900 New	15,900 $210,000
Q4 2020 Feb 08, 2021	SELL	$45.3 - $60.27 $747,450 - $994,455	-16,500 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$47.45 - $62.95 $251,485 - $333,635	-5,300 Reduced 24.31%	16,500 $116,000
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $276,415 - $360,195	-5,900 Reduced 21.3%	21,800 $22,000
Q1 2020 May 11, 2020	BUY	$41.6 - $63.4 $1.15 Million - $1.76 Million	27,700 New	27,700 $292,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.